Mylan Pharmaceuticals Inc. v. Merck Sharp & Dohme Corp. (Fed. Cir. 2022) | McDonnell Boehnen Hulbert & Berghoff LLP

The Federal Circuit affirmed the Patent Trial and Appeal Board's (PTAB) Final Written Decision (FWD) in an inter partes review (IPR) that Mylan Pharmaceuticals failed to show the claims...

Related Keywords

,Mylan Pharmaceuticals ,International Patent Publication No ,Merck Sharp Dohme Corp ,Mylan Pharmaceuticals Inc ,Federal Circuit ,Patent Trial ,Appeal Board ,Final Written Decision ,International Patent Publication ,Judge Lourie ,Judges Reyna ,Regarding Mylan ,Circuit Judges Lourie ,Circuit Judge ,